Increased serum thrombopoietin concentration in systemic sclerosis associated with myelofibrosis and thrombocytosis [5]

Joint Bone Spine

Volumn 73, Issue 1, 2006, Pages 122-123

  Ozturk, M Akif ^a   Haznedaroglu, Seminur ^a   Karaaslan, Yasar ^b   Goker, Berna ^a   Haznedaroglu, Ibrahim C ^c  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b ANKARA NUMUNE HOSPITAL   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Myelofibrosis; Systemic sclerosis; Thrombopoietin

Indexed keywords

CORTICOSTEROID; HYDROXYUREA; IMMUNOSUPPRESSIVE AGENT; THROMBOPOIETIN;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ADULT; ANAMNESIS; BLOOD LEVEL; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; FEMALE; HEPATOMEGALY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LETTER; MYELOFIBROSIS; PHYSICAL EXAMINATION; SPLENOMEGALY; SYSTEMIC SCLEROSIS; THROMBOCYTOSIS; TREATMENT OUTCOME; VEIN THROMBOSIS;

BIOLOGICAL MARKERS; FEMALE; HUMANS; MIDDLE AGED; MYELOFIBROSIS; SCLERODERMA, SYSTEMIC; THROMBOCYTOSIS; THROMBOPOIETIN;

EID: 32044470076     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2005.04.005     Document Type: Letter

References (10)

1. S. Ozaki, M. Kosaka, K. Ozaki, S. Wakatsuki, T. Hashimoto, and H. Miyazaki Thrombopoietin-responsive essential thrombocytemia with myelofibrosis Br. J. Haematol. 97 1997 449 452
2. X.Q. Yan, D. Lacey, D. Hill, Y. Chen, F. Fletcher, and R.G. Hawley A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation Blood 88 1996 402 409
3. T.R. Ulich, J. del Castillo, G. Senaldi, O. Kinstler, S. Yin, and S. Kaufman Systemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in mice Blood 87 1996 5006 5015
4. D.E. Furst, and P.J. Clements Hypothesis for the pathogenesis of systemic sclerosis J. Rheumatol. 24 Suppl. 1997 S53 S57
5. D.J. Kuter, and R.D. Rosenberg The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit Blood 85 1995 2720 2730
6. S. Kiraz, I. Ertenli, M.A. Ozturk, I.C. Haznedaroglu, I. Celik, and S. Kirazli Bloodstream thrombopoietin in rheumatoid arthritis with thrombocytosis Clin. Rheumatol. 21 2002 453 456
7. P Caramaschi, S Canestrimi, D Biasi, N Martinelli, L Perbellini, and A Carletto Evaluation of finger skin temperature in scleroderma patients cyclically treated with iloprost Joint Bone Spine 73 2005
8. S. Karakus, O.I. Ozcebe, I.C. Haznedaroglu, H. Goker, D. Ozatli, and A. Kosar Circulating thrombopoietin in clonal versus reactive thrombocytosis Hematology (Am. Soc. Hematol. Educ. Program) 7 2002 9 12
9. I.C. Haznedaroglu, H. Goker, M. Turgut, Y. Buyukasik, and M. Benekli Thrombopoietin as a drug: biologic expectations, clinical realities, and future directions Clin. Appl. Thromb. Hemost. 8 2002 193 212
10. I. Ertenli, S. Kiraz, H. Erturk, I.C. Haznedaroglu, I. Celik, and M. Calguneri Circulating thrombopoietin in systemic sclerosis J. Rheumatol. 26 1999 1939 1941